Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-23-073415
Filing Date
2023-06-21
Accepted
2023-06-21 17:24:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 POS AM tm2317766d1_posam.htm POS AM 682982
2 EXHIBIT 23.1 tm2317766d1_ex23-1.htm EX-23.1 2453
3 EX-FILING FEES tm2317766d1_ex-filingfees.htm EX-FILING FEES 45954
4 GRAPHIC tm2317766d1_posamimg01.jpg GRAPHIC 10915
5 GRAPHIC tm2317766d1_posamsp1img001.jpg GRAPHIC 3360
6 GRAPHIC tm2317766d1_posamsp4img002.jpg GRAPHIC 3573
  Complete submission text file 0001104659-23-073415.txt   757547
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-261888 | Film No.: 231030901
SIC: 2836 Biological Products, (No Diagnostic Substances)